Berlin, Germany
April 7 - April 8, 2006
Psoriasis is a chronic, life-ruining disease for many patients and there is significant unmet clinical need in the management of patients with moderate to severe psoriasis. Notwithstanding these unmet needs, there have been few significant developments in the treatment for moderate to severe psoriasis in the last 10-15 years. Today, an entirely new approach to therapy has been made possible as a result of the increased understanding of the pathogenesis of psoriasis.
This symposium will provide an overview of the immunopathology of psoriasis. The way in which our understanding of the immunological basis of psoriasis has contributed to our ability to develop targeted biological therapies will also be presented.
The assessment of psoriasis “burden” is not an exact science and the definition of “burden” will inevitably differ between dermatologists and patients. A review of how psoriasis “burden” is assessed will be presented.
Biological therapies provide a new hope for many patients. The integration of these new biologicals into clinical practice will be considered.
OBJECTIVES
After attending this symposium, the participants will have an updated knowledge on:
- The role of T cells in psoriasis pathogenesis
- The main strategies for biological immunotherapy for psoriasis
- Psoriasis burden assessment
- The rationale for the use of new biological therapies for psoriasis
- The integration of biologicals into clinical practice
TARGET AUDIENCE
Clinicians and scientists as well as nurses involved in the management of psoriasis will benefit from this symposium.
Serono Symposia International Foundation (www.seronosymposia.org) has submitted the following CME activity for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME). The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.be.
This program, “The Changing Face of Psoriasis Management” (7–8 April 2006, Berlin, Germany) has been approved by EACCME for a maximum of 9 (nine) hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
The Royal College of Physicians, London, UK, has accredited this Serono Symposia International Foundation symposium with 8 (eight) credit hours (Reference number: 30501).
The Ärztekammer Berlin (Germany) has accredited this Serono Symposia International Foundation symposium with 10 (ten) credit hours.
This program, “The Changing Face of Psoriasis Management” (7–8 April 2006, Berlin, Germany) has been submitted for CME accreditation from the Italian Ministry of Health (Reference number: 10045-231921).